NRNils Reiss

Nils Reiss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nils Reiss has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Surgical Removal of Occluder Devices: Complications and Pitfalls

    by Nils Reiss, Ulrich Schuett, Ariane Maleszka, Georg Kleikamp, Soren Schenk, Jan Gummert

    Metapress is the fastest-growing resource of expert content online -- Discover more about what interests you, learn new skills, and find inspiration.


  • Circulatory assistance in small infants and neonates with a hydraulically driven system: a viable option?

    by Nils Reiss, Reiner Körfer

    We have developed a new drive system for a cardiac assist system for use with newborns and infants. This study reports results of animal experiments in which this system was tested using a commercially available 25-ml ventricle. A major property of the device is its hydraulic mode, which allows not only for the conventional full-empty mode (chamber completely filled in diastole) but also for the filled-empty mode, in which the chamber is completely emptied in systole but only partially filled in systole; this mode gives full flexibility to adjust the pump frequency for any given pump flow rate. The assist device was applied in eight pigs (weight 9–14 kg) for left ventricular assistance during normal and impaired cardiac function (pacing-induced cardiac shock, mean arterial blood pressure less than 40 mmHg). Both, full-empty and filled-empty mode during normal cardiac function led to significantly decreased pulmonary capillary wedge pressure, suggesting load reduction of the right ventricle. In impaired cardiac function, circulatory assistance increased the diminished cardiac output and systolic arterial blood pressure, although only the latter was statistically significant. Neither arterial lactate concentration nor oxygen uptake was reduced during circulatory assistance for normal and impaired cardiac function. These results suggest that the cardiac ventricular assist device can be used as an effective circulatory assist device and that the function of the newly introduced filled-empty mode, which allows for a high degree of functional flexibility, is not inferior to that of the classical, but less flexible, full-empty mode.


  • New Method for Sternal Closure After Vacuum-Assisted Therapy in Deep Sternal Infections After Cardiac Surgery

    by Nils Reiss, Ulrich Schuett, Michael Kemper, Andreas Bairaktaris, Reiner Koerfer


  • Initial Experience with the Medtronic ADVANTAGE Valve Prosthesis in the Mitral Position - Clinical Outcome and Analysis of Complications

    by N. Reiss, D. Seifert, H. Koertke, A. Hoffmann-Koch, G. Kleikamp, A. Bairaktaris, R. Koerfer

    Objective: The Medtronic ADVANTAGE prosthetic heart valve is a bileaflet mechanical heart valve which has two main design modifications. The prosthesis has an enlarged central orifice to improve blood flow characteristics and an asymmetric butterfly pivot recess with expanded outflow component designed to enhance the blood flow washing through the pivot region. This report summarizes the initial experience with 55 patients who underwent isolated mitral valve replacement. Methods: We prospectively followed 55 patients undergoing mitral valve replacement with the Medtronic ADVANTAGE prosthesis in a single center study. All patients were operated on via a median sternotomy and a left atrial approach. Results: The age of the patients at implant ranged from 42 years to 77 years with a mean of 61.8 years. Forty-five percent of the patients were male. Seventy-five percent of the patients were in NYHA functional class III or IV prior to valve replacement. The diameters of the implanted prostheses were as follows: 25 mm in 2 patients, 27 mm in 12 patients, 29 mm in 20 patients, and 31 mm in 21 patients. Coronary artery bypass grafting was performed with valve replacement in 16.4 % of patients and additional tricuspid repair in 10.9 %. After one year, 97.6 % and after two years 100 % of the included patients were in NYHA functional class I or II. All patients had Coumadin (warfarin) therapy postoperatively with a target INR range of 2.5 to 3.5, or 3.0 to 4.0. There were 4 thromboembolic events (7.3 %) in the early period and 2 late events (2.6 %). Episodes of valve thrombosis were not seen during the follow-up, which consisted of 76.5 patient years. The hemodynamic performance was favorable and within clinically acceptable ranges. The incidence of valve-related mortality and morbidity in this preliminary study was extremely low, indicating good clinical results comparable to those reported for other bileaflet valves. Conclusion: The ADVANTAGE valve is a safe and effective option for mitral valve replacement with a very low incidence of valve-related complications.


  • Mechanical valve replacement of the systemic atrioventricular valve in children.

    by Nils Reiss, U Blanz, T Breymann, K Kind, A Bairaktaris, R Körfer

    In children with systemic atrioventricular valve disease (SAVVD), reconstructive surgery is the primary goal. However, in cases with severely dysplastic valves or failed repair, valve replacement is the only option. The purpose of this study was to assess the early and late outcome following mechanical valve replacement in SAVVD. Between 1989 and 2003, 31 children underwent mechanical valve replacement (19 St. Jude Medical, 12 Carbomedics) in SAVVD (27 mitral, 3 tricuspid in corrected transposition of the great arteries, 1 common in an univentricular heart) at our institution. The ages ranged from 3 months to 15 years (mean 4 years) and body weight varied between 4.2 and 57 kg (mean 13.3 kg). The size of prostheses ranged between 16 and 31 mm (mean 23.9 mm). The main indication for valve replacement was severe insufficiency of left atrioventricular valve (84%); 84% of the patients had had a previous cardiac operation. The overall hospital mortality was 6.5% The mean follow up was 7.7 years (range 2-13 years). Ninety percent of children represent sinus rhythm, 87% are in NYHA class I. All patients were placed on a regimen of Phenprocoumon aiming to maintain the international normalized ratio (INR) between 3.0 and 4.0. Since 1994, INR self-management of oral anticoagulation was performed either by the patient or his or her parents. There was no anticoagulation-related complication in this patient group. Mechanical valve replacement in left atrioventricular valve disease carries a low operative risk across the spectrum of pediatric age despite previous operations in most cases. Long-term survival and quality of life are good in nearly all cases. The rate of anticoagulation-related complications is very low, especially when INR self management is performed.